Norma K. Biln

BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Patient and Rheumatologist Perspectives of the Patient SAID Tool (Self-Administered Inflammatory Arthritis Detection): Implementation Considerations, Potential Barriers, and Opportunities.

Patient and Rheumatologist Perspectives of the Patient SAID Tool (Self-Administered Inflammatory Arthritis Detection): Implementation Considerations, Potential Barriers, and Opportunities.

Journal: The Journal of rheumatology

Published: February 15, 2026

Patient and Rheumatologist Perspectives of the Patient Self-Administered Inflammatory Arthritis Detection Tool: Implementation Considerations, Potential Barriers, and Opportunities.

Patient and Rheumatologist Perspectives of the Patient Self-Administered Inflammatory Arthritis Detection Tool: Implementation Considerations, Potential Barriers, and Opportunities.

Journal: The Journal of rheumatology

Published: December 24, 2025

The Patient Self-Administered Inflammatory Arthritis Detection Study.

The Patient Self-Administered Inflammatory Arthritis Detection Study.

Journal: The Journal of rheumatology

Published: October 30, 2025

A scoping review of triage approaches for the referral of patients with suspected inflammatory arthritis, from primary to rheumatology care.

A scoping review of triage approaches for the referral of patients with suspected inflammatory arthritis, from primary to rheumatology care.

Journal: Rheumatology international

Published: October 20, 2023

The Association of Rheumatologist Supply and Multidisciplinary Care With Timely Patient Access to Rheumatologists: Evidence From British Columbia, Canada.

The Association of Rheumatologist Supply and Multidisciplinary Care With Timely Patient Access to Rheumatologists: Evidence From British Columbia, Canada.

Journal: Arthritis care & research

Published: June 29, 2023

Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial.

Serum 14-3-3η as predictor of clinical remission and progression of structural damage in early rheumatoid arthritis following a treat-to-target strategy in a randomized controlled trial.

Journal: Scandinavian journal of rheumatology

Published: July 14, 2022

Patient Perspectives on a Digital Mobile Health Application for RA.

Patient Perspectives on a Digital Mobile Health Application for RA.

Journal: Open access rheumatology : research and reviews

Published: December 23, 2020

Impending radiographic erosive progression over the following year in a cohort of consecutive patients with inflammatory polyarthritis: prediction by serum biomarkers.

Impending radiographic erosive progression over the following year in a cohort of consecutive patients with inflammatory polyarthritis: prediction by serum biomarkers.

Journal: RMD open

Published: January 23, 2020

Tumour necrosis factor alpha promotes secretion of 14-3-3η by inducing necroptosis in macrophages.

Tumour necrosis factor alpha promotes secretion of 14-3-3η by inducing necroptosis in macrophages.

Journal: Arthritis research & therapy

Published: July 22, 2019

The diagnostic value of 14-3-3η protein levels in patients with rheumatoid arthritis.

The diagnostic value of 14-3-3η protein levels in patients with rheumatoid arthritis.

Journal: Best practice & research. Clinical rheumatology

Published: June 09, 2019

Decrease in 14-3-3η protein levels is correlated with improvement in disease activity in patients with rheumatoid arthritis treated with Tofacitinib.

Decrease in 14-3-3η protein levels is correlated with improvement in disease activity in patients with rheumatoid arthritis treated with Tofacitinib.

Journal: Pharmacological research

Published: August 27, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026